Gleevec remains effective in advanced GIST, with median overall survival of 75.3 months and significant long-term survival rates. Factors like female sex, gastric tumor location, smaller tumors, and ...
Patients need long-term monitoring after gastrointestinal stromal tumor surgery, with some requiring extra treatment or genetic testing to lower recurrence risk. Follow-up care and monitoring remain ...
Gastrointestinal stromal tumours (GISTs) are rare stomach tumours driven by KIT or PDGFRA gene mutations. Unlike typical ...
Personalized tumor-informed circulating tumor DNA analysis in monitoring recurrence following resection of high-risk locally advanced stage gastrointestinal stromal tumor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results